These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 31809217)

  • 61. Consumer and treatment provider perspectives on reducing barriers to opioid substitution treatment and improving treatment attractiveness.
    Deering DEA; Sheridan J; Sellman JD; Adamson SJ; Pooley S; Robertson R; Henderson C
    Addict Behav; 2011 Jun; 36(6):636-642. PubMed ID: 21276664
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Barriers to care for rural people living with HIV: a review of domestic research and health care models.
    Pellowski JA
    J Assoc Nurses AIDS Care; 2013; 24(5):422-37. PubMed ID: 23352771
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Telehealth services in rural and remote Australia: a systematic review of models of care and factors influencing success and sustainability.
    Bradford NK; Caffery LJ; Smith AC
    Rural Remote Health; 2016; 16(4):3808. PubMed ID: 27744708
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Buprenorphine in the United States: Motives for abuse, misuse, and diversion.
    Chilcoat HD; Amick HR; Sherwood MR; Dunn KE
    J Subst Abuse Treat; 2019 Sep; 104():148-157. PubMed ID: 31370979
    [TBL] [Abstract][Full Text] [Related]  

  • 65. County-level access to opioid use disorder medications in medicare Part D (2010-2015).
    Abraham AJ; Adams GB; Bradford AC; Bradford WD
    Health Serv Res; 2019 Apr; 54(2):390-398. PubMed ID: 30665272
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Facilitators and barriers in implementing buprenorphine in the Veterans Health Administration.
    Gordon AJ; Kavanagh G; Krumm M; Ramgopal R; Paidisetty S; Aghevli M; Goodman F; Trafton J; Liberto J
    Psychol Addict Behav; 2011 Jun; 25(2):215-24. PubMed ID: 21480679
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Opioid-related treatment, interventions, and outcomes among incarcerated persons: A systematic review.
    Malta M; Varatharajan T; Russell C; Pang M; Bonato S; Fischer B
    PLoS Med; 2019 Dec; 16(12):e1003002. PubMed ID: 31891578
    [TBL] [Abstract][Full Text] [Related]  

  • 68. "It's more than Just a Job to Them": A Qualitative Examination of Patient and Provider Perspectives on Medication-Assisted Treatment for Opioid Use Disorder.
    Filteau MR; Kim FL; Green B
    Community Ment Health J; 2022 Feb; 58(2):321-327. PubMed ID: 33844126
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Structural barriers in the context of opiate substitution treatment in Germany--a survey among physicians in primary care.
    Schulte B; Schmidt CS; Kuhnigk O; Schäfer I; Fischer B; Wedemeyer H; Reimer J
    Subst Abuse Treat Prev Policy; 2013 Jul; 8():26. PubMed ID: 23875627
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties.
    Stein BD; Pacula RL; Gordon AJ; Burns RM; Leslie DL; Sorbero MJ; Bauhoff S; Mandell TW; Dick AW
    Milbank Q; 2015 Sep; 93(3):561-83. PubMed ID: 26350930
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Provider experiences with relaxing restrictions on take-home medications for opioid use disorder during the COVID-19 pandemic: A qualitative systematic review.
    Adams A; Blawatt S; MacDonald S; Finnick R; Lajeunesse J; Harrison S; Byres D; Schechter MT; Oviedo-Joekes E
    Int J Drug Policy; 2023 Jul; 117():104058. PubMed ID: 37182352
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Group-based treatment of opioid use disorder with buprenorphine: A systematic review.
    Sokol R; LaVertu AE; Morrill D; Albanese C; Schuman-Olivier Z
    J Subst Abuse Treat; 2018 Jan; 84():78-87. PubMed ID: 29195596
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Telehealth services in rural and remote Australia: a systematic review of models of care and factors influencing success and sustainability.
    Bradford NK; Caffery LJ; Smith AC
    Rural Remote Health; 2016; 16(4):4268. PubMed ID: 27817199
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Barriers and facilitators to HPV vaccine uptake among US rural populations: a scoping review.
    Peterson CE; Silva A; Holt HK; Balanean A; Goben AH; Dykens JA
    Cancer Causes Control; 2020 Sep; 31(9):801-814. PubMed ID: 32537702
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Peer support for people with chronic conditions in rural areas: a scoping review.
    Lauckner HM; Hutchinson SL
    Rural Remote Health; 2016; 16(1):3601. PubMed ID: 26943760
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Healthcare providers' perspectives of providing primary healthcare services to persons with physical disabilities in rural Ghana.
    Dassah E; Aldersey HM; McColl MA; Davison C
    Prim Health Care Res Dev; 2019 Jul; 20():e108. PubMed ID: 32799998
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Medical termination of pregnancy service delivery in the context of decentralization: social and structural influences.
    Hulme-Chambers A; Clune S; Tomnay J
    Int J Equity Health; 2018 Nov; 17(1):172. PubMed ID: 30463561
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Overcoming Barriers to Sustained Engagement in Mental Health Care: Perspectives of Rural Veterans and Providers.
    Fischer EP; McSweeney JC; Wright P; Cheney A; Curran GM; Henderson K; Fortney JC
    J Rural Health; 2016 Sep; 32(4):429-438. PubMed ID: 27557334
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Barriers of colorectal cancer screening in rural USA: a systematic review.
    Wang H; Roy S; Kim J; Farazi PA; Siahpush M; Su D
    Rural Remote Health; 2019 Aug; 19(3):5181. PubMed ID: 31394041
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.